U.S., Jan. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07313813) titled 'A Study to Evaluate the Effect of Fasting Duration and Dulaglutide (LY2189265) Withholding on Gastric Retention in Participants With Type 2 Diabetes Mellitus' on Dec. 18, 2025.
Brief Summary: The purpose of this study is to evaluate how fasting and stopping the use of Dulaglutide (LY2189265) affect the amount of food and drink that stays in your stomach after a meal.
Ultrasound devices will be used to check the stomach content after a test meal.
The study can last approximately 28 weeks.
Study Start Date: Dec., 2025
Study Type: INTERVENTIONAL
Condition:
Type 2 Diabetes Mellitus (T2DM)
Intervention:
DRUG: Dulaglutide
Administ...